Cell MedX Corp. Quarterly Common Stock, Shares Authorized from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Cell MedX Corp. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2010 to Q3 2024.
  • Cell MedX Corp. Common Stock, Shares Authorized for the quarter ending August 31, 2024 was 7.5B shares, a 2400% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 7.5B +7.2B +2400% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 7.5B 0 0% May 31, 2024 10-Q 2024-10-15
Q1 2024 7.5B +7.2B +2400% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 300M 0 0% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 300M 0 0% Aug 31, 2023 10-Q 2023-10-16
Q2 2023 7.5B +7.2B +2400% May 31, 2023 10-K 2024-08-29
Q1 2023 300M 0 0% Feb 28, 2023 10-Q 2023-06-29
Q4 2022 300M 0 0% Nov 30, 2022 10-Q 2023-05-19
Q3 2022 300M 0 0% Aug 31, 2022 10-Q 2023-04-19
Q2 2022 300M 0 0% May 31, 2022 10-K 2023-09-01
Q1 2022 300M 0 0% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 300M 0 0% Nov 30, 2021 10-Q 2022-01-12
Q3 2021 300M 0 0% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 300M 0 0% May 31, 2021 10-K 2023-04-07
Q1 2021 300M 0 0% Feb 28, 2021 10-Q 2021-04-09
Q4 2020 300M 0 0% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 300M 0 0% Aug 31, 2020 10-Q 2020-10-15
Q2 2020 300M 0 0% May 31, 2020 10-Q 2021-04-09
Q1 2020 300M 0 0% Feb 29, 2020 10-Q 2020-04-14
Q4 2019 300M 0 0% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 300M 0 0% Aug 31, 2019 10-Q 2019-10-15
Q2 2019 300M 0 0% May 31, 2019 10-K 2020-09-15
Q1 2019 300M 0 0% Feb 28, 2019 10-Q 2019-04-22
Q4 2018 300M 0 0% Nov 30, 2018 10-Q 2019-01-14
Q3 2018 300M 0 0% Aug 31, 2018 10-Q/A 2018-10-16
Q2 2018 300M 0 0% May 31, 2018 10-K 2019-09-06
Q1 2018 300M 0 0% Feb 28, 2018 10-Q 2018-04-16
Q4 2017 300M 0 0% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 300M 0 0% Aug 31, 2017 10-Q 2017-10-17
Q2 2017 300M 0 0% May 31, 2017 10-K 2018-09-13
Q1 2017 300M 0 0% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 300M 0 0% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 300M 0 0% Aug 31, 2016 10-Q 2016-10-17
Q2 2016 300M 0 0% May 31, 2016 10-K 2017-08-29
Q1 2016 300M 0 0% Feb 29, 2016 10-Q 2016-04-14
Q4 2015 300M 0 0% Nov 30, 2015 10-Q 2016-01-14
Q3 2015 300M 0 0% Aug 31, 2015 10-Q 2015-10-15
Q2 2015 300M 0 0% May 31, 2015 10-K 2016-09-13
Q1 2015 300M 0 0% Feb 28, 2015 10-Q 2015-04-14
Q4 2014 300M 0 0% Nov 30, 2014 10-Q 2015-01-14
Q3 2014 300M 0 0% Aug 31, 2014 10-Q 2014-10-09
Q2 2014 300M 0 0% May 31, 2014 10-K 2015-09-03
Q1 2014 300M 0 0% Feb 28, 2014 10-Q/A 2014-07-17
Q4 2013 300M 0 0% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 300M 0 0% Aug 31, 2013 10-Q 2013-10-03
Q2 2013 300M 0 0% May 31, 2013 10-K 2014-08-26
Q1 2013 300M 0 0% Feb 28, 2013 10-Q 2013-04-15
Q4 2012 300M 0 0% Nov 30, 2012 10-Q 2013-01-16
Q3 2012 300M 0 0% Aug 31, 2012 10-Q 2012-10-15
Q2 2012 300M 0 0% May 31, 2012 10-K/A 2014-07-17
Q1 2012 300M Feb 29, 2012 10-Q 2012-04-09
Q4 2011 300M Nov 30, 2011 10-Q 2012-03-02
Q3 2011 300M Aug 31, 2011 10-Q 2011-10-17
Q2 2011 300M May 31, 2011 10-K 2012-10-11
Q1 2010 300M Mar 19, 2010 10-Q 2015-01-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.